Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors
about
Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptorSeven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Pharmacology of signaling induced by dopamine D(1)-like receptor activationThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesThe potential for selective pharmacological therapies through biased receptor signalingEpigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.Differential activation and trafficking of micro-opioid receptors in brain slices.Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonistsTherapeutic potential of β-arrestin- and G protein-biased agonists.Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.G protein coupled receptors as allosteric proteins and the role of allosteric modulators.Dopamine receptor signaling and current and future antipsychotic drugs.Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor.
P2860
Q26864383-20FA01FA-51EC-493E-854B-554DF5D257DDQ28472395-F3BC6460-9ED2-4BB9-8AA9-C0D8205C28EDQ33890786-96F01A6E-E028-40F1-84D5-67DDA7CA826CQ34126949-0F52AECE-031D-4982-B371-010DD3087D1EQ34329204-48EB7C16-9490-4CB0-B991-0FDEC98EBF95Q34402658-A018C493-C6CD-4D4A-8716-E26EAAF6646BQ35063181-640643E6-DD85-4326-A9BB-4A04034D4FB9Q35076051-DABBB62F-A56C-40E3-899F-F3565B00EFC8Q35913125-7D3E378E-4388-47ED-B1B3-01A66BA183D2Q36773331-9E03EAF9-AEB5-4918-9953-FD4012F83284Q37610141-6B0FD892-3FDE-42EF-B0B5-3D12F3BF94D4Q37790693-80FFCF88-C0AA-4026-AA78-9E44BE7F27D6Q38058009-E3EA2944-5301-4257-B742-9CCE0D90C9E0Q38762256-5B48B8A8-CA39-457B-BD02-2C6736B070CCQ39021630-7072EE7A-D96A-4030-B999-43915B85D0CDQ39884754-1F2DF3C2-CA0D-498C-AC97-05B7727D20B7Q42213049-D8180B83-C5CC-4FD4-9FC2-0E4FA88CA2E3Q49463637-412EACDF-CAC6-4B4B-AF00-D97F6CF6E021
P2860
Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Functional selectivity of dopa ...... fate of internalized receptors
@ast
Functional selectivity of dopa ...... fate of internalized receptors
@en
Functional selectivity of dopa ...... fate of internalized receptors
@nl
type
label
Functional selectivity of dopa ...... fate of internalized receptors
@ast
Functional selectivity of dopa ...... fate of internalized receptors
@en
Functional selectivity of dopa ...... fate of internalized receptors
@nl
prefLabel
Functional selectivity of dopa ...... fate of internalized receptors
@ast
Functional selectivity of dopa ...... fate of internalized receptors
@en
Functional selectivity of dopa ...... fate of internalized receptors
@nl
P2093
P2860
P1433
P1476
Functional selectivity of dopa ...... fate of internalized receptors
@en
P2093
Adam Griffith
Jessica P Ryman-Rasmussen
Justin T Brown
Richard B Mailman
Scott Oloff
William A Goddard
P2860
P304
P356
10.1016/J.NEUROPHARM.2006.08.028
P407
P577
2007-02-01T00:00:00Z